Position in CYTK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,082,338
+$293,462 QoQ
Shares Held
12,705
+6.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#257
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. CYTK ranks #12 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,455 | $28,042,892 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,412 | $12,104,158 | |
| 3 | TECH |
BIO-TECHNE Corp
|
68,452 | $4,836,133 | |
| 4 | INCY |
Incyte Corp
|
26,479 | $3,001,659 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,139 | $2,751,113 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
48,369 | $2,275,277 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
6,111 | $2,045,901 | |
| 8 | EXEL |
Exelixis, Inc.
|
36,758 | $2,000,002 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,082,338 | 12,705 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $788,876 | 11,969 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $728,359 | 11,463 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $633,743 | 11,531 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $336,776 | 10,193 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $594,771 | 14,799 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $691,111 | 14,692 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $795,273 | 15,062 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $792,761 | 14,632 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,025,358 | 14,625 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,694,930 | 20,301 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $597,743 | 20,290 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $662,022 | 20,295 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $552,658 | 15,705 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $722,352 | 15,765 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $768,659 | 15,865 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $617,245 | 15,710 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $449,450 | 12,210 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $674,356 | 14,795 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $453,898 | 12,700 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $210,169 | 10,620 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $247,021 | 10,620 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $178,708 | 8,600 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $215,417 | 9,950 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $183,846 | 7,800 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $88,425 | 7,500 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||